did the fda ban tirzepatide 🚨 Moves to Permanently Shut Down Compounded GLP-1s FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these FDA BANS Compounded Tirzepatide! Now

Oral Dis 24(12):138143 de Azevedo AB, Dos Santos T, Lopes MA, Pires FR (2021) Oral leukoplakia, leukoerythroplakia, erythroplakia and actinic cheilitis: Analysis of 953 patients focusing on oral epithelial dysplasia

Cardioprotective Effects: Potential to protect heart cells and reduce cardiovascular risk

This latest research involved 50 people diagnosed with moderate to severe alcohol use disorder (AUD)

Tobaiqy, M., & Elkout, H

Improved exercise performance: Better fat utilization can help spare glycogen stores, allowing athletes to maintain performance for longer before fatigue appears

Research has shown that individuals taking GLP-1 RAs may experience a reduction in muscle mass